CLSI: Clinical And Laboratory Standards Institute
Molecules | Free Full-Text | Evaluation of an Element-Tagged Duplex Immunoassay Coupled with Inductively Coupled Plasma Mass Spectrometry Detection: A Further Study for the Application of the New Assay in Clinical Laboratory
CLSI EP07 (R2022)
CLSI EP09
EP07: Interference Testing in Clinical Chemistry, 3rd Edition
Relevant CLSI Reference Materials1
CLSI EP5-A3 Evaluation of Precision of Quantitative Measurement Procedures – Approved Guideline
Autonomous Clinical Chemistry Assay Design
EP17-A2: Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline—Second Edition
CLSI EP28-A3C Definition, Festlegung und Verifizierung von Referenzbereichen im klinischen Labor
Clsi-Catalog Web Links042414 | PDF | Immunoassay | Medical Laboratory
Free Resources From CLSI
Performance evaluation for in vitro diagnostics
Clinical and Laboratory Standards Institute - CLSI has created a list of documents helpful for the laboratory community's use during the current COVID-19 pandemic. View it here. >> http://ow.ly/rDLF50z3HMj | Facebook
Interference Testing: Why following Standards is Not Always the Right Thing to Do
Table 2 from Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care | Semantic Scholar
CLSI EP07 (R2022)
アテリカCH Li II（第2版）
Sample: Interference Testing in Clinical Chemistry Approved Guideline-Second Edition | PDF | Quality Management System | Medical Laboratory
PDF) EP07 Interference Testing in Clinical Chemistry A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process
Analytical Performance for FDA/CE submissions, and OQC/ IQC - zimmerandpeacock
NCCLS Guidelines
CLSI EP7-A2 Intervention Testing in Clinical Chemistry - Approved Guideline
